ND2 EVALUATIONS OF THE PRESCRIBED DAILY DOSES OF TRANSDERMAL FENTANYL AND TRANSDERMAL BUPRENORPHINE IN CANCERAND NON-CANCER PATIENTS IN GERMANY: RESULTS FROM A RETROSPECTIVE DATABASE ANALYSIS
2006 ◽
Vol 9
(3)
◽
pp. A22
G Haerdtl
◽
U Niemann
◽
MC Nuijten
◽
B Poulsen Nautrup
2014 ◽
Vol 32
(15_suppl)
◽
pp. 1603-1603
Nina Schmidt
◽
Gabriele Haas
◽
Karel Kostev
◽
Peyman Hadji
2018 ◽
Vol 34
(10)
◽
pp. 1855-1860
◽
Joerg Mahlich
◽
Akiko Tsubota
◽
Keiichiro Imanaka
◽
Kentaro Enjo
Ayumi Shintani
◽
Tebeb Gebretsadik
◽
Svetlana Eden
Emir M. Muzurović
◽
Sanja Borozan
2018 ◽
Vol 113
(Supplement)
◽
pp. S353
◽
Timothy W. Smith
◽
Marco DiBonaventura
◽
David Gruben
◽
Danielle Bargo
◽
Leonardo Salese
◽
...
Nelu Nadejde
◽
Yassir Lemseffer
◽
Laurent Desmurs
◽
Sabine Zaepfel
◽
Flora Kaczorowski
◽
...
2017 ◽
Vol 30
(10)
◽
pp. 1002-1010
◽
An Martens
◽
Dirk E Van Raemdonck
◽
Jacqueline Smits
◽
Stijn E Verleden
◽
Robin Vos
◽
...
2020 ◽
Vol 26
(12)
◽
pp. 1529-1537
David R Axon
◽
Shannon Vaffis
◽
Chanadda Chinthammit
◽
Breanne E Lott
◽
Ann M Taylor
◽
...
2014 ◽
Vol 8
(3)
◽
pp. 250-255
◽
Karel Kostev
◽
Achim Jockwig
◽
Alexander Hallwachs
◽
Wolfgang Rathmann
Close
Export Citation Format
Close
Share Document
Close